# Antibody After COVID-19 Vaccination

> **NCT05057936** · — · COMPLETED · sponsor: **Bangkok Metropolitan Administration Medical College and Vajira Hospital** · enrollment: 140 (actual)

## Conditions studied

- Covid19
- Breakthrough Infection
- CKD
- Kidney Transplant
- Vaccination

## Interventions

- **BIOLOGICAL:** COVID vaccine

## Key facts

- **NCT ID:** NCT05057936
- **Lead sponsor:** Bangkok Metropolitan Administration Medical College and Vajira Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05057936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05057936, "Antibody After COVID-19 Vaccination". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05057936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*